The Latest Cardiac and Vascular News
LEUVEN, Belgium and STAMFORD, Conn., Sept. 15, 2020 /PRNewswire/ — LindaCare announces the appointment of Donald Deyo to Chairman and Chief Executive Officer of the LindaCare NV. Deyo has served as Chairman of the Board for the Company since 2017. LindaCare is a digital health company specializing in integrated remote cardiac monitoring software and services. The […]
– FDA Fast Track designation facilitates the development of potential new therapies that treat serious conditions and fulfill an unmet medical need – This Fast Track designation for empagliflozin emphasizes the urgent need for potential treatments that may improve outcomes following an acute myocardial infarction, more commonly known as a […]
Positive responses confirm that the PURE EP signals are preferred to conventional sources of intracardiac signals in a blinded, independent analysis. Abstract concludes PURE EP™ System is able to produce reliable and high-quality signals when compared to the available standard of care systems. Westport, CT, Sept. 15, 2020 (GLOBE NEWSWIRE) […]
Heart valve disease is a common, serious but treatable condition, often associated with ageing, yet only 3% of older Canadians are aware of its most common formi Survey shows huge variance across Canada in use of simple stethoscope check to pick up characteristic ‘murmur’ of the heart valves, from 60% […]
– FDA Agreement to Move Directly into Phase 3 – – FDA to Require a Single Phase 3 Trial of 12 Weeks Duration to Support Efficacy for an NDA filing in SHTG – BEDMINSTER, N.J., Sept. 15, 2020 (GLOBE NEWSWIRE) — Matinas BioPharma Holdings, Inc. (NYSE AMER: MTNB), a clinical-stage biopharmaceutical company focused […]
PETOSKEY, Mich.–(BUSINESS WIRE)–BioStar Capital, a value-add investment firm focused on transformational medical device technologies that serve unmet patient needs in cardiovascular and orthopedic medicine, today announced that Mark Toland, former CEO of Corindus Vascular Robotics, a Siemens Healthineers and BioStar portfolio company, has joined the firm as a partner and […]
Experienced Cardiologist Brings Expertise in Launching and Scaling Innovative Models of Care SAN FRANCISCO–(BUSINESS WIRE)–Element Science, an innovative health technology company pioneering a next-generation digital wearable platform for high-risk cardiovascular patients transitioning from hospital to home, announced today that it has appointed Zubin J. Eapen, MD, MHS, FACC, FAHA, as […]
Supporting recently approved First-in-Human clinical trial at Keio University, accelerating company-sponsored clinical trials, and building a strong foundation for further growth TOKYO–(BUSINESS WIRE)–Heartseed Inc. (hereinafter Heartseed), a Tokyo-based biotechnology company developing iPSC-derived cardiomyocyte spheroids for the treatment of heart failure (HF), today announced that Mutsuki Takano has been appointed as Chief […]
SEATTLE–(BUSINESS WIRE)–Curi Bio, a leading developer of human stem cell-based platforms for drug discovery, today announced the Mantarray™ platform for human-relevant 3D engineered muscle tissue (EMT) analysis. Curi’s Mantarray platform enables the discovery, safety, and efficacy testing of new therapeutics by providing parallel analysis of 3D EMTs with adult human-like […]
With FDA 510(k) clearance and CE mark, the Fitbit ECG App may help prevent serious complications like stroke by allowing users to spot check for signs of AFib from their wrist SAN FRANCISCO–(BUSINESS WIRE)–Fitbit (NYSE:FIT) has received 510(k) clearance from the U.S. Food and Drug Administration (FDA), as well as Conformité Européenne (CE) marking […]
